Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-24-020821
Filing Date
2024-12-17
Accepted
2024-12-17 20:44:40
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3714
  Complete submission text file 0001062993-24-020821.txt   5509
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Davis Todd C (Reporting) CIK: 0001392029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 241557418

Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)